Nomura Asset Management CO LTD Gilead Sciences, Inc. Transaction History
Nomura Asset Management CO LTD
- $35.5 Billion
- Q2 2025
A detailed history of Nomura Asset Management CO LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Nomura Asset Management CO LTD holds 784,675 shares of GILD stock, worth $92.9 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
784,675
Previous 876,522
10.48%
Holding current value
$92.9 Million
Previous $98.2 Million
11.42%
% of portfolio
0.24%
Previous 0.31%
Shares
43 transactions
Others Institutions Holding GILD
# of Institutions
2,346Shares Held
1.03BCall Options Held
12.1MPut Options Held
9.13M-
Black Rock Inc. New York, NY121MShares$14.3 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.1 Billion0.22% of portfolio
-
State Street Corp Boston, MA59.2MShares$7.01 Billion0.25% of portfolio
-
Capital World Investors Los Angeles, CA46.3MShares$5.48 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA37.5MShares$4.45 Billion0.79% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $148B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...